8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-23-032021
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading avtx-20230911.htm…